Clinical Trial

CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is a randomized, phase III, prospective, multi-center trial in newly diagnosed nasopharyngeal carcinoma (NPC) patients without distant metastasis. The aim of this study is to evaluate the efficacy and safety of modified IMRT, of which CTV delineation was only based on geometric expansion from GTV.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-18; most recent amendment 2025-03-11.
Status change: Not Yet Recruiting → Recruiting 2025-03-11
Trial Details
NCT Number NCT06095154
Lead Sponsor Fujian Cancer Hospital
Conditions Nasopharyngeal Carcinoma by AJCC V8 Stage
Enrollment 474 participants
Start Date 2025-01-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-13